BullishAgent BullishAgent Filings Market Earnings Ratings ETFs Insiders Shorts
Screener Research
Sign in Register
Portfolio (Quarterly) Guide ↗

Ishara Investments LP

· CIK 0002111609
13F Portfolio $87M AUM Filed Feb 17, 2026 EDGAR ↗ ← All Funds
Q1 2026 Q4 2025 · All 38 New
Page 1 of 2  ·  38 positions
# Ticker Company Sector Shares Value ↓ % Port Chg Shares Chg % Period Price ① Since Period ①
1 PRAXIS PRECISION MEDICINES I 40,000.0 $11.8M 13.48% NEW $294.74
2 XERS XERIS BIOPHARMA HOLDINGS INC Healthcare 800,000.0 $6.3M 7.18% NEW $7.85 -20.6%
3 BMRN BIOMARIN PHARMACEUTICAL INC Healthcare 100,000.0 $5.9M 6.79% NEW $59.43 -9.0%
4 FOLD AMICUS THERAPEUTICS INC Healthcare 360,000.0 $5.1M 5.86% NEW $14.24 +1.8%
5 ACAD ACADIA PHARMACEUTICALS INC Healthcare 160,000.0 $4.3M 4.89% NEW $26.71 -20.2%
6 ANNX ANNEXON INC Healthcare 750,000.0 $3.8M 4.30% NEW $5.02 +8.4%
7 NUVB NUVATION BIO INC Healthcare 400,000.0 $3.6M 4.10% NEW $8.96 -46.5%
8 BBIO BRIDGEBIO PHARMA INC Healthcare 36,000.0 $2.8M 3.15% NEW $76.49 -8.1%
9 PTCT PTC THERAPEUTICS INC Healthcare 36,000.0 $2.7M 3.13% NEW $75.96 -6.5%
10 UTHR UNITED THERAPEUTICS CORP DEL Healthcare 5,500.0 $2.7M 3.06% NEW $487.25 +15.7%
11 BCRX BIOCRYST PHARMACEUTICALS INC Healthcare 300,000.0 $2.3M 2.68% NEW $7.80 +7.3%
12 PCVX VAXCYTE INC Healthcare 50,000.0 $2.3M 2.64% NEW $46.14 +2.7%
13 GMAB GENMAB A/S Healthcare 70,000.0 $2.2M 2.46% NEW $30.80 -12.2%
14 SNDX SYNDAX PHARMACEUTICALS INC Healthcare 100,000.0 $2.1M 2.40% NEW $21.01 -4.2%
15 VERASTEM INC 270,000.0 $2.1M 2.38% NEW $7.72
16 TARS TARSUS PHARMACEUTICALS INC Healthcare 24,000.0 $2.0M 2.25% NEW $81.88 -20.9%
17 APOG APOGEE ENTERPRISES INC Industrials 25,000.0 $1.9M 2.16% NEW $75.48 -53.2%
18 ZNTL ZENTALIS PHARMACEUTICALS INC Healthcare 1,320,000.0 $1.8M 2.04% NEW $1.35 +174.8%
19 INSM INSMED INC Healthcare 10,000.0 $1.7M 1.99% NEW $174.04 -37.1%
20 CORT CALL CORCEPT THERAPEUTICS INC Healthcare 44,000.0 $1.5M 1.75% NEW $34.80 +71.5%
Page 1 of 2  ·  38 positions

Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.

Sector Allocation
Healthcare 97.3%
Industrials 2.7%